Discovery Life Sciences Appoints Govt Vice President to Assist Speedy Progress in Proteomics


HUNTSVILLE, Ala., Aug. 23, 2022 /PRNewswire/ — Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, right now introduced the appointment of Michael Pisano, Ph.D. as  govt vp of proteomics. Dr. Pisano brings to Discovery greater than twenty years of govt management and administration expertise within the proteomics and broader life sciences house. On this position, Dr. Pisano is spearheading the enlargement of Discovery’s current biomarker discovery companies to incorporate an array of proteomic platforms that can complement its current genomic and tissue biomarker companies to help biomarker analysis comprehensively. 

“Michael is a extremely skilled and acknowledged chief in proteomics, and we’re excited to have him on the Discovery staff to bolster our biomarker discovery capabilities,” stated Jay Scherer, Discovery’s chief working officer. “Our imaginative and prescient is to be a distinguished, complete proteomics service supplier for our prospects from discovery to medical segments throughout the pharma, biotech, and diagnostic industries. We’re happy that he has joined the Discovery staff as the following step ahead in his profound profession journey. We’re assured that he’ll play a central position to assist us obtain our imaginative and prescient.”

Earlier than becoming a member of Discovery, Dr. Pisano served as vp of enterprise improvement and contract analysis at Cayman Chemical. Throughout his eight-year tenure, he held roles of accelerating accountability that culminated within the launch of a brand new contract companies division. Beforehand, he held senior administration positions in varied life science corporations. As an entrepreneur, he efficiently began a contract analysis group for biomarker and proteomic analysis, which he grew to profitability and bought.

“Discovery’s purpose is to propel proteomics over the brink to full adoption within the drug discovery pipeline,” stated Dr. Pisano. “The addition of proteomics to our service portfolio means Discovery now can ship on multi-omic initiatives, as we at present present genomics, IHC, and stream cytometry, with plans to supply lipidomics and metabolomics within the close to future. I’m excited to be part of Discovery’s technique to construct this one-stop-shop expertise for biomarker discovery and improvement companies.”

About Discovery Life Sciences and HudsonAlpha Discovery

Discovery Life Sciences is the corporate of biospecimen and biomarker specialists, combining the world’s largest industrial biospecimen stock and procurement community with preeminent multi-omic biomarker service laboratories to speed up precision medication packages for most cancers, infectious illness, and different advanced situations. We’re a number one supplier of extremely characterised human mobile beginning supplies and knowledgeable multi-omic analytical companies to advance cell and gene remedy analysis, improvement, and manufacturing packages.

HudsonAlpha Discovery® is Discovery’s sequencing and bioinformatics division, a globally acknowledged service laboratory that leverages probably the most present genomic analysis applied sciences to comprehensively help discovery, translational, and medical analysis. 

Pushed by science, the Discovery staff engages with prospects in an revolutionary, consultative method to overcoming obstacles and reaching a quicker finish end result. We’re Science at your Service™! For extra info, go to dls.com.

SOURCE Discovery Life Sciences



Supply hyperlink